1. Modified internucleoside linkages for nuclease-resistant oligonucleotides
   Guillaume Clavé et al, 2021, RSC Chemical Biology CrossRef
2. Telomerase and Telomeres Biology in Thyroid Cancer
   Benedetta Donati et al, 2019, International Journal of Molecular Sciences CrossRef
3. Diminazene or berenil, a classic duplex minor groove binder, binds to G-quadruplexes with low nanomolar dissociation constants and the amidine groups are also critical for G-quadruplex binding
   Jie Zhou et al, 2014, Mol. BioSyst. CrossRef
4. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
   Mark Barszczyk et al, 2014, Acta Neuropathologica CrossRef
5. Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
   Adam Eckburg et al, 2020, Cancers CrossRef
6. Comprehensive analysis of telomerase inhibition by gallotannin
   Nikita Savelyev et al, 2018, Oncotarget CrossRef
7. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor
   Yafang Hu et al, 2014, Cancer Genetics CrossRef
8. Therapeutic targeting of replicative immortality
   Paul Yaswen et al, 2015, Seminars in Cancer Biology CrossRef
9. Emerging therapies for the treatment of essential thrombocythemia
   Adolfo Enrique Diaz et al, 2018, Expert Opinion on Orphan Drugs CrossRef
10. Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
    Martina Gatzka, 2018, Cancers CrossRef
11. Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
    Nicola Relitti et al, 2020, Current Topics in Medicinal Chemistry CrossRef
12. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
    Jillian E. Koziel et al, 2015, Breast Cancer Research and Treatment CrossRef
13. Oligonucleotide inhibitors of telomerase: Prospects for anticancer therapy and diagnostics
    M. I. Zvereva et al, 2015, Biochemistry (Moscow) CrossRef
14. Oligonucleotides Targeting Telomeres and Telomerase in Cancer
    Zachary Schrank et al, 2018, Molecules CrossRef
15. Therapeutic strategies for targeting telomerase in cancer
    Xing Chen et al, 2020, Medicinal Research Reviews CrossRef
16. Non-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance
    Connor A.H. Thompson et al, 2020, Current Topics in Medicinal Chemistry CrossRef
17. Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis
    A.J. Valentijn et al, 2015, Human Reproduction CrossRef
18. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma
    Yafang Hu et al, 2015, Cancer Biology & Therapy CrossRef
19. Research progress of small-molecule drugs in targeting telomerase in human cancer and aging
    Ziyi Shen et al, 2023, Chemico-Biological Interactions CrossRef
20. Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
    Yoshiko Maida et al, 2015, Cancer Science CrossRef
21. Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma
    Sylvain Ferrandon et al, 2015, Molecular Cancer CrossRef
22. Antisense oligonucleotides: modifications and clinical trials
    Vivek K. Sharma et al, 2014, Med. Chem. Commun. CrossRef
23. BRD4 and Cancer: going beyond transcriptional regulation
    Benedetta Donati et al, 2018, Molecular Cancer CrossRef
24. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways
    Somayyeh Ghareghomi et al, 2021, Biochimie CrossRef
25. Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
    Liu Yang et al, 2021, Oncology Reports CrossRef